Natural health product–drug interaction tool

Abstract

Get full access to this article

View all access options for this article.

References

Health Canada. Natural Health Product Tracking Survey–2010. Ipsos-Reid. Available: http://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2011/135-09/report.pdf (accessed Dec. 2, 2015).

Izzo

Ernst

. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs 2009;69:1777-98.

Necyk

Tsuyuki

Boon

. Pharmacy study of natural health product reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality. BMJ Open 2014;4:e003431. doi:10.1136/bmjopen-2013-003431.

Esmail

. Complementary and alternative medicine in Canada: trends in use and public attitudes 1997-2006. Public Policy Sources 2007;87:1-53.

Konefal

. The challenge of educating physicians about complementary and alternative medicine. Acad Med 2002;77:847-50.

Cvijovic

Boon

Barnes

. A tool for rapid identification of potential herbal medicine–drug interactions. Can Pharm J (Ott) 2009;142:224-7.

Vohra

Cvijovic

Boon

. Study of natural health product adverse reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies. PLoS ONE 2012;7:e45196.

Natural Medicines Database. Available: https://naturalmedicines.therapeuticresearch.com/databases.aspx (accessed Jun. 24, 2015).

Williamson

Driver

Baxter

Preston

, editors. Stockley’s herbal medicines interactions. London (UK): Pharmaceutical Press. Available: http://www.medicinescomplete.com/mc/shmi/current/ (accessed Dec. 18, 2014).

10.

Stargrove

Treasure

McKee

. Herb, nutrient, and drug interactions: clinical implications and therapeutic strategies. St. Louis (MO): Mosby/Elsevier; 2008.

11.

Genzzanni

Sorrentino

. Vascular action of acteina: active constituent of Actaea racemosa L. Nature 1962(194):544-5.

12.

Gupta

Tandon

. Antinociceptive activity of Vitex negundo Linn leaf extract. Indian J Physiol Pharmacol 2005;49:163-70.

13.

Circosta

Occhiuto

Ragusa

. A drug used in traditional medicine: Harpagophytum procumbens DC. II. Cardiovascular activity. J Ethnopharmacol 1984;11:259-74.

14.

Tsao

Yin

. In vitro activity of garlic oil and four diallyl sulphides against antibiotic-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae. J Antimicrob Chemother 2001;47:665-70.

15.

Nagoshi

Shiota

Kuroda

. Synergistic effect of [10]-gingerol and aminoglycosides against vancomycin-resistant enterococci (VRE). Biol Pharm Bull 2006;29:443-7.

16.

Jung

Chang

Kim

. Effects of ginkgo biloba extract on the cochlear damage induced by local gentamicin installation in guinea pigs. J Korean Med Sci 1998;13:525-8.

17.

Dasgupta

Actor

. Effect of Asian and Siberian ginseng on serum digoxin measurement by five digoxin immunoassays: significant variation in digoxin-like immunoreactivity among commercial ginsengs. Am J Clin Pathol 2003;119:298-303.

18.

Jeon

Kim

. Effect of Korean red ginseng on blood pressure and nitric oxide production. Acta Pharmacologica Sin 2000;21:1095-100.

19.

Kimura

Saunders

Kim

. Interactions of ginsenosides with ligand-bindings of GABA(A) and GABA(B) receptors. Gen Pharmacol 1994;25:193-9.

20.

Tsang

Yeung

Tso

. Ginseng saponins: influence on neurotransmitter uptake in rat brain synaptosomes. Planta Medica 1985;51:221-4.

21.

Ofir

Tamir

Khatib

. Inhibition of serotonin re-uptake by licorice constituents. J Mol Neurosci 2003;20:135-40.

22.

Hussain

. Silymarin as an adjunct to glibenclamide therapy improves long-term and postprandial glycemic control and body mass index in type 2 diabetes. J Med Food 2007;10:543-7.

23.

Gardiner

Adams

Filippelli

. A systematic review of the reporting of adverse events associated with medical herb use among children. Glob Adv Health Med 2013;2:46-55.

24.

Fugh-Berman

Ernst

. Herb–drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 2001;52:587-95.

25.

Goey

Mooiman

Beijnen

. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb–drug interactions in cancer patients. Cancer Treat Rev 2013;39:773-83.

26.

Higgins

JPT

Green

, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. Cochrane Collaboration; 2011. Available: http://handbook.cochrane.org (accessed Dec. 2, 2015).

27.

Zorzela

Golder

Liu

. Quality of reporting in systematic reviews of adverse events: a systematic review. BMJ 2014;8:348.

28.

Charrois

Hill

. Community identification of natural health product-drug interactions. Ann Pharmacother 2007;41:1124-29.

29.

Barnes

. Quality, efficacy, and safety of complementary medicines: fashions, facts, and the future. Part II: efficacy and safety. Br J Clin Pharmacol 2003;55:331-40.

30.

van Grootheest

Olsson

Couper

de Jong-van den Berg

. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf 2004;13:457-64.

31.

Barnes

Mills

Abbot

. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies. Br J Clin Pharmacol 1998;45:496-500.

32.

Barnes

. Pharmacovigilance of herbal medicines. Drug Safety 2003;26:829-51.

33.

Wiktorowicz

Lexchin

Moscou

. Keeping an eye on prescription drugs, keeping Canadians safe: a commissioned discussion paper. Health Council of Canada. 2010. Available: http://publications.gc.ca/collections/collection_2011/ccs-hcc/H174-21-2010-eng.pdf (accessed Dec. 2, 2015).

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.10 MB